- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 973KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 328KB)
Dapagliflozin – July 2023
Dapagliflozin: Tablet 10 mg; Forxiga®
Last updated
27 October 2023